Brooks Laboratories Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Excellent return on equity (ROE 22%)
- Efficient capital deployment (ROCE 21.2%)
- Attractively valued vs sector (P/E 12.2x vs industry 50.2x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BROOKS · as of Jun 2026
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.59% | 63.59% | 63.59% | 59.06% | 52.62% | 52.62% |
| FII | — | — | 0.02% | 0.01% | 0.05% | — |
| DII | 3.86% | 3.86% | 3.86% | 3.86% | 10.38% | 10.38% |
| Public | 32.55% | 32.55% | 32.53% | 37.08% | 36.95% | 37.00% |
Latest News
All newsBrooks Laboratories announces general corporate updates
*Brooks Laboratories announces general corporate updates.* The company filed routine updates with the NSE, though specific details were not disclosed. Such filings typically include administrative or procedural information. **No major financial or operational changes** were indicated. 📊 *STOCKS:* BROOKS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate
Brooks Labs re-lodges transfer deed, publishes notice
*Brooks Labs re-lodges transfer deed as per regulatory norms.* **Newspaper publication** confirms re-lodgement process is underway. This follows standard corporate procedure for share transfers. No immediate financial impact expected. 📊 *STOCKS:* BROOKS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #TransferDeed